Part 1Parole and other release from detention
Release: Rules
74ARules about drug and alcohol testing and monitoring
The chief executive may
make rules for all or any of the following purposes:- prescribing, for the purposes of section 16B(2)(a) and (c), 1 or more types of testing procedure that an offender to whom section 16B applies may be required to undergo:
- specifying how often each of the prescribed testing procedures may be carried out:
- prohibiting authorised persons from requiring an offender to undergo certain testing procedures if other less intrusive testing procedures are available and are sufficient in the circumstances:
- prescribing, for the purposes of section 16B(2)(b), 1 or more types of drug or alcohol monitoring device that may be connected to an offender to whom section 16B applies:
- specifying restrictions as to how often, and for how long,—
- continuous monitoring may be carried out:
- an offender may be required to contact an automated system:
- continuous monitoring may be carried out:
- prescribing, for any 1 or more of the following, minimum levels that must be present in a bodily sample collected from an offender in order for the sample to be used as evidence that the offender has breached a drug or alcohol condition:
- controlled drugs:
- psychoactive substances:
- alcohol.
- controlled drugs:
Rules under this section are secondary legislation (see Part 3 of the Legislation Act 2019 for publication requirements).
Notes
- Section 74A: inserted, on , by section 10 of the Parole (Drug and Alcohol Testing) Amendment Act 2016 (2016 No 84).
- Section 74A(1): amended, on , by section 3 of the Secondary Legislation Act 2021 (2021 No 7).
- Section 74A(2): inserted, on , by section 3 of the Secondary Legislation Act 2021 (2021 No 7).


